CureMetrix Company
CureMetrix is committed to advancing AI-based technology that improves breast cancer and heart disease detection across the globe.
Founded Date:
2014
Estimated Revenue:
$1M to $10M
Investors Number:
2
Employee Number:
11-50
Last Funding Type:
Series A
Industry:
Med Tech
Technology:
['BioTech & HealthTech']
Headquarters:
San Diego, California, United States
Funding Status:
Early Stage Venture
Last Funding Date:
2017-01-01